Stockscreener 앱 받기
19.97
1.47%
0.29
시간 외 거래:
19.58
-0.39
-1.95%
Upstream Bio Inc 주식(UPB)의 최신 뉴스
Upstream Bio Inc. stock momentum explained2025 Price Momentum & Expert Approved Trade Ideas - Newser
Is Upstream Bio Inc. meeting your algorithmic filter criteriaWeekly Trade Report & Safe Capital Growth Trade Ideas - Newser
Long term hold vs stop loss in Upstream Bio Inc.2025 Price Momentum & Target Return Focused Stock Picks - Newser
Visual trend scoring systems applied to Upstream Bio Inc.M&A Rumor & Daily Stock Trend Reports - Newser
Historical volatility pattern of Upstream Bio Inc. visualizedEarnings Miss & Community Supported Trade Ideas - Newser
Using fundamentals and technicals on Upstream Bio Inc.Trade Analysis Summary & Weekly Stock Breakout Alerts - Newser
Statistical indicators supporting Upstream Bio Inc.’s strength2025 Analyst Calls & Technical Confirmation Trade Alerts - Newser
Using portfolio simulators with Upstream Bio Inc. included2025 Buyback Activity & Expert Verified Stock Movement Alerts - Newser
How to interpret RSI for Upstream Bio Inc. stock2025 Market Sentiment & Safe Entry Trade Reports - Newser
Upstream Bio’s Phase 2 VIBRANT Trial Results and Strategic Implications for Long-Term Growth - AInvest
Is Upstream Bio Inc. stock poised for growthMarket Performance Summary & Consistent Profit Focused Trading Strategies - Newser
Is now a turning point for Upstream Bio Inc.Portfolio Gains Report & Accurate Buy Signal Notifications - Newser
Will Upstream Bio Inc. benefit from geopolitical trendsJuly 2025 Catalysts & Short-Term Swing Trade Alerts - خودرو بانک
Can Upstream Bio Inc. outperform in the next rally2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - خودرو بانک
Is Upstream Bio Inc. stock a top performer YTDWeekly Trend Report & Free Safe Capital Growth Stock Tips - خودرو بانک
Transcript : Upstream Bio, Inc.Special Call - MarketScreener
Is Upstream Bio Inc. forming a bottoming baseJuly 2025 Market Mood & Real-Time Stock Movement Alerts - Newser
Trend analysis for Upstream Bio Inc. this weekPortfolio Growth Summary & Real-Time Chart Pattern Alerts - Newser
Using economic indicators to assess Upstream Bio Inc. potentialJuly 2025 Retail & AI Enhanced Trade Execution Alerts - Newser
Technical signs of recovery in Upstream Bio Inc.2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - Newser
Exit strategy if you’re trapped in Upstream Bio Inc.Trade Entry Summary & Verified Short-Term Plans - Newser
Upstream Bio Initiates Phase 2 Clinical Trial for COPD Drug, Verekitug - MSN
What MACD and RSI say about Upstream Bio Inc.2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser
How to build a dashboard for Upstream Bio Inc. stock2025 Top Gainers & Fast Gain Stock Tips - Newser
Real time breakdown of Upstream Bio Inc. stock performanceMarket Performance Recap & High Accuracy Swing Entry Alerts - Newser
Analyzing Upstream Bio Inc. with risk reward ratio chartsWeekly Profit Analysis & High Conviction Buy Zone Alerts - Newser
Does Upstream Bio Inc. offer margin of safetyMarket Risk Report & Capital Efficiency Focused Strategies - خودرو بانک
Will Upstream Bio Inc. outperform during market ralliesMarket Sentiment Report & Daily Entry Point Trade Alerts - خودرو بانک
Upstream Bio Inc. stock outlook for YEAR2025 Momentum Check & High Win Rate Trade Alerts - Newser
Is Upstream Bio Inc. a strong candidate for buy and holdQuarterly Trade Review & Reliable Breakout Stock Forecasts - خودرو بانک
Upstream Bio Announces Positive Phase 2 Trial Results - The Globe and Mail
Developing predictive dashboards with Upstream Bio Inc. dataRate Cut & Technical Pattern Recognition Alerts - Newser
Upstream Bio shares rise 1.18% premarket after reporting positive top-line results from the Phase 2 VIBrant trial of Verekitug for the treatment of chronic rhinosinusitis with nasal polyps. - AInvest
Upstream Bio, Inc. $UPB Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Signal strength of Upstream Bio Inc. stock in tech scannersRecession Risk & Low Drawdown Investment Ideas - Newser
Upstream Bio Reports Positive Top-Line Results from the - GlobeNewswire
Upstream Bio Shares Surge 18.27% on Strong Phase 2 Trial Data for Verekitug - AInvest
Technical Heatmap Flags Upstream Bio Inc. for WatchCPI Data & Safe Entry Zone Tips - beatles.ru
Verekitug heads to late-stage trials after Phase II success - Yahoo Finance
Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial FindsUpstream Bio (NASDAQ:UPB) - Benzinga
Upstream Bio’s Phase 2 win could set it up as a potential Dupixent, Tezspire competitor - Endpoints News
1.40%
자본화:
|
볼륨(24시간):